Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Piotr Adamowicz. (2021) Blood concentrations of synthetic cathinones. Clinical Toxicology 59:7, pages 648-654.
Read now
Read now
Olof Beck, Matilda Bäckberg, Patrick Signell & Anders Helander. (2018) Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats. Clinical Toxicology 56:4, pages 256-263.
Read now
Read now
Anders Helander, Matilda Bäckberg, Patrick Signell & Olof Beck. (2017) Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project. Clinical Toxicology 55:6, pages 589-599.
Read now
Read now
Katrin Romanek, Jochen Stenzel, Sabrina Schmoll, Verena Schrettl, Stefanie Geith, Florian Eyer & Christian Rabe. (2017) Synthetic cathinones in Southern Germany – characteristics of users, substance-patterns, co-ingestions, and complications. Clinical Toxicology 55:6, pages 573-578.
Read now
Read now
Anders Helander & Matilda Bäckberg. (2017) New Psychoactive Substances (NPS) – the Hydra monster of recreational drugs. Clinical Toxicology 55:1, pages 1-3.
Read now
Read now
Matilda Bäckberg, Jenny Westerbergh, Olof Beck & Anders Helander. (2016) Adverse events related to the new psychoactive substance 3-fluorophenmetrazine – results from the Swedish STRIDA project. Clinical Toxicology 54:9, pages 819-825.
Read now
Read now
Olof Beck, Lisa Franzén, Matilda Bäckberg, Patrick Signell & Anders Helander. (2016) Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clinical Toxicology 54:7, pages 568-575.
Read now
Read now
Anders Helander, Matilda Bäckberg & Olof Beck. (2016) Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clinical Toxicology 54:4, pages 324-332.
Read now
Read now
Articles from other publishers (36)
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, Ornella Corazza, Aurora Coppola & Gianluca Esposito. (2023) The novel psychoactive substances epidemic: A scientometric perspective. Addiction Neuroscience 5, pages 100060.
Crossref
Crossref
M.A. Vinnikova & V.V. Severtsev. (2023) Risk factors for the development of psychotic disorders associated with synthetic cathinones usage. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 123:5, pages 153.
Crossref
Crossref
Vy T. Nguyen, Alan C. Harris Jr.Jose M. Eltit. 2023.
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
131
156
.
Kerry Layne, Paul I. Dargan & David M. Wood. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
333
380
.
Fabio De-Giorgio, Eva Bergamin, Sabrine Bilel, Micaela Tirri, Raffaella Arfè, Beatrice Marchetti, Giorgia Corli, Giovanni Serpelloni & Matteo Marti. (2021) Ethanol enhanced MDPV- and cocaine-induced aggressive behavior in mice: Forensic implications. Drug and Alcohol Dependence 229, pages 109125.
Crossref
Crossref
H-H Chou, C-H Hsieh, C-H Chaou, C-K Chen, T-H Yen, S-C Liao, C-J Seak & H-Y Chen. (2021) Synthetic cathinone poisoning from ingestion of drug-laced “instant coffee packets” in Taiwan. Human & Experimental Toxicology 40:9, pages 1403-1412.
Crossref
Crossref
Deborah Rudin, Matthias E. Liechti & Dino Luethi. (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology 343, pages 113778.
Crossref
Crossref
Liane D. Paul, Jessica Welter-Luedeke, Saskia Penzel, Anna Zangl & Matthias Graw. (2021) Alpha-Pyrrolidinopentiothiophenone (α-PVT): A forensic case study including plasma concentrations. Forensic Science International 321, pages 110721.
Crossref
Crossref
Yoshifumi Morikawa, Hidetoshi Miyazono, Yuji Sakai, Koichi Suenami, Yasuhide Sasajima, Kiyohito Sato, Yuji Takekoshi, Yasunari Monguchi, Akira Ikari & Toshiyuki Matsunaga. (2020) 4′-Fluoropyrrolidinononanophenone elicits neuronal cell apoptosis through elevating production of reactive oxygen and nitrogen species. Forensic Toxicology 39:1, pages 123-133.
Crossref
Crossref
Bruno Mégarbane, Mathieu Oberlin, Jean-Claude Alvarez, Frederic Balen, Sébastien Beaune, Régis Bédry, Anthony Chauvin, Isabelle Claudet, Vincent Danel, Guillaume Debaty, Arnaud Delahaye, Nicolas Deye, Jean-Michel Gaulier, Francis Grossenbacher, Philippe Hantson, Frédéric Jacobs, Karim Jaffal, Magali Labadie, Laurence Labat, Jérôme Langrand, Frédéric Lapostolle, Philippe Le Conte, Maxime Maignan, Patrick Nisse, Philippe Sauder, Christine Tournoud, Dominique Vodovar, Sebastian Voicu, Pierre-Géraud Claret & Charles Cerf. (2020) Management of pharmaceutical and recreational drug poisoning. Annals of Intensive Care 10:1.
Crossref
Crossref
Grigory M. Usov & Sergey A. Rakitin. (2020) Clinical structure of psychoses, associated with use of modern synthetic psychoactive substances. Neurology Bulletin LII:2, pages 40-45.
Crossref
Crossref
Anders Helander, Matilda Bäckberg & Olof Beck. (2020) Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PLOS ONE 15:4, pages e0232038.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Fabio De-Giorgio, Sabrine Bilel, Andrea Ossato, Micaela Tirri, Raffaella Arfè, Federica Foti, Giovanni Serpelloni, Paolo Frisoni, Margherita Neri & Matteo Marti. (2019) Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications. International Journal of Legal Medicine 133:6, pages 1797-1808.
Crossref
Crossref
Xun Zhou, Dino Luethi, Gerda Sanvee, Jamal Bouitbir, Matthias Liechti & Stephan Krähenbühl. (2019) Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts. International Journal of Molecular Sciences 20:7, pages 1561.
Crossref
Crossref
Jessica Welter‐Luedeke & Hans H. Maurer. (2018) Relevance of published blood concentrations of new psychoactive substance for rational case interpretation. WIREs Forensic Science 1:1.
Crossref
Crossref
Lisa Franzén, Matilda Bäckberg, Olof Beck & Anders Helander. (2018) Acute Intoxications Involving α-Pyrrolidinobutiophenone (α-PBP): Results from the Swedish STRIDA Project. Journal of Medical Toxicology 14:4, pages 265-271.
Crossref
Crossref
Luis M. Colon-Perez, Jose A. Pino, Kaustuv Saha, Marjory Pompilus, Sherman Kaplitz, Nafisa Choudhury, Darin A. Jagnarine, Jean R. Geste, Brandon A. Levin, Isaac Wilks, Barry Setlow, Adriaan W. Bruijnzeel, Habibeh Khoshbouei, Gonzalo E. Torres & Marcelo Febo. (2018) Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone. Neuropharmacology 137, pages 178-193.
Crossref
Crossref
László I. Gerecsei, András Csillag, Gergely Zachar, Lőrinc Gévai, László Simon, Árpád Dobolyi & Ágota Ádám. (2018) Gestational Exposure to the Synthetic Cathinone Methylenedioxypyrovalerone Results in Reduced Maternal Care and Behavioral Alterations in Mouse Pups. Frontiers in Neuroscience 12.
Crossref
Crossref
Marco Diestelmann, Anna Zangl, Inge Herrle, Eva Koch, Matthias Graw & Liane D. Paul. (2018) MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations. Forensic Science International 283, pages 72-84.
Crossref
Crossref
Steven J. Simmons, Ryan A. Gregg, Fionya H. Tran, Lili Mo, Eva von Weltin, David J. Barker, Taylor A. Gentile, Lucas R. Watterson, Scott M. Rawls & John W. Muschamp. (2018) Comparing rewarding and reinforcing properties between ‘bath salt’ 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats. Addiction Biology 23:1, pages 102-110.
Crossref
Crossref
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances
475
494
.
Anders Helander & Matilda Bäckberg. 2018. New Psychoactive Substances. New Psychoactive Substances
461
473
.
Lea Wagmann & Hans H. Maurer. 2018. New Psychoactive Substances. New Psychoactive Substances
413
439
.
Michael D. Hambuchen, Howard P. Hendrickson, Melinda G. Gunnell, Samantha J. McClenahan, Laura E. Ewing, Dillon M. Gibson, Michael D. Berquist & S. Michael Owens. (2017) The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats. Drug and Alcohol Dependence 179, pages 347-354.
Crossref
Crossref
Rose Cairns & Nicholas A. Buckley. (2017) The Poisoning Severity Score: If It Did Not Exist, We Would Have To Invent It. Journal of Medical Toxicology 13:2, pages 131-134.
Crossref
Crossref
Anders Helander. 2017. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation
83
99
.
A. Helander, M. Bradley, A. Hasselblad, L. Norlén, I. Vassilaki, M. Bäckberg & J. Lapins. (2017) Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45. British Journal of Dermatology 176:4, pages 1021-1027.
Crossref
Crossref
Marcel Grapp, Christoph Kaufmann & Martin Ebbecke. (2017) Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): Detection, quantification and studies on human metabolism by GC–MS. Forensic Science International 273, pages 1-9.
Crossref
Crossref
Michael D. Hambuchen, Howard P. Hendrickson & S. Michael Owens. (2017) Chiral determination of 3,4-methylenedioxypyrovalerone enantiomers in rat serum. Analytical Methods 9:4, pages 609-617.
Crossref
Crossref
Charles W Schindler, Eric B Thorndike, Masaki Suzuki, Kenner C Rice & Michael H Baumann. (2016) Pharmacological mechanisms underlying the cardiovascular effects of the “bath salt” constituent 3,4-methylenedioxypyrovalerone (MDPV). British Journal of Pharmacology 173:24, pages 3492-3501.
Crossref
Crossref
Markus R. Meyer. (2016) New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics. Archives of Toxicology 90:10, pages 2421-2444.
Crossref
Crossref
Hector Rosas-Hernandez, Elvis Cuevas, Susan M. Lantz, Kenner C. Rice, Brenda M. Gannon, William E. Fantegrossi, Carmen Gonzalez, Merle G. Paule & Syed F. Ali. (2016) Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells. Neuroscience Letters 629, pages 125-130.
Crossref
Crossref
Markus R. Meyer & Hans H. Maurer. (2016) Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices – Where do we stand today?. Analytica Chimica Acta 927, pages 13-20.
Crossref
Crossref
Elisabeth Leere Øiestad, Åse Marit Leere Øiestad, Astrid Gjelstad & Ritva Karinen. (2016) Oral fluid drug analysis in the age of new psychoactive substances. Bioanalysis 8:7, pages 691-710.
Crossref
Crossref